Sarepta Therapeutics
SRPT
SRPT
411 hedge funds and large institutions have $10.8B invested in Sarepta Therapeutics in 2024 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 145 increasing their positions, 122 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
19% more repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 122
4% more funds holding
Funds holding: 394 → 411 (+17)
0.43% less ownership
Funds ownership: 89.11% → 88.68% (-0.43%)
Holders
411
Holding in Top 10
15
Calls
$649M
Puts
$198M
Top Buyers
| 1 | +$161M | |
| 2 | +$141M | |
| 3 | +$140M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$68.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$60.8M |
Top Sellers
| 1 | -$242M | |
| 2 | -$114M | |
| 3 | -$72.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$58.8M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$48.2M |